Stage 4 lymphoma is a blood cancer that has spread outside of the lymph nodes to other parts of the body. Learn the symptoms, ...

A patient with relapsed follicular lymphoma achieved complete remission one month after PMB-CT01 treatment in the phase 1 PMB ...

STARLIGHT-1 trial has dosed the first patient in the second cohort of the study evaluating EB103 in advanced B-cell ...

SIDNEY is an ongoing Phase 2 trial of EO2463 in 48 indolent Non-Hodgkin Lymphoma (iNHL) patients Enterome has held a positive Type-C meeting with FDA for EO2463 in iNHL Enterome to attend Jefferies ...

The trial is set to take place at sites across several European countries including Spain, the UK and Belgium.

The findings suggest assessment of CD20 may be an important factor in determining treatment options in B-cell lymphomas.

As the lump in Makaila Chenier's neck grew, it became difficult for her to breathe. That's when she knew she needed to see a ...

Iksuda Therapeutics (Iksuda), the developer of class-leading antibody drug conjugates (ADCs) with clinically validated tumour-selective payload release formats, today announces the completion of ...

The Nordic Protocol is a type of chemoimmunotherapy treatment. It combines chemotherapy (which aims to destroy cancer cells) ...

High-risk populations with aggressive B-cell lymphoma worthy of consideration include patients with high-risk international prognostic index (IPI) scores, patients with activated B-cell (ABC; or ...

Extended follow-up results beyond 2.5 years from the pivotal NHL-1 EPCORE trial: Subcutaneous epcoritamab monotherapy in patients with relapsed/refractory large B-cell lymphoma (R/R LBCL). Impact of ...